Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 172,540 shares at $3.71 ($664K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.71 | 31,541 | $117K | 17.6% |
| 2 | $3.71 | 31,541 | $117K | 17.6% |
| 3 | $3.90 | 40,999 | $160K | 24.1% |
| 4 | $3.90 | 40,999 | $160K | 24.1% |
| 5 | $4.00 | 27,460 | $110K | 16.6% |
| Total | $3.85 avg | 172,540 |
| $664K |
| 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |